Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Efficacy and Safety of ES-481, a Novel TARP Inhibitor, in Drug-resistant Epilepsy: A Double-blind Randomized Placebo Controlled Phase IIa Trial

              Author:O'Brien, Terence   Foster, Emma   Millist, Lyn   Germaine, Jack   Chamorro, Stephanie   Roberts, Caitlyn   Nicolo, John Paul   Hosking, Sean   Perucca, Piero   Mullen, Saul   Robinson, Heather   Wharrie, Bec   Walsh, Brittany   Reutens, David   Irwin, Kimberley   Chen, Michael   Niecestro, Robert   

              Session Name:S19: Epilepsy Clinical Trials and Long-term Studies  

              Topic:Epilepsy/Clinical Neurophysiology (EEG)  

              Program Number:S19.003  

              Author Institution:Monash University, Melbourne, Vic, Australia  Alfred Health, Melbourne, Vic, Australia  The Royal Melbourne Hospital, Parkville, Vic, Australia  Austin Health, Heidelberg, Australia  Austin Health, Heidelburg, Vic , Australia  The Royal Brisbane and Womens Hospital, Herston, QLD, Australia  ES Therapeutics, New York, NY